Mediators of Inflammation
Volume 2006 (2006), Article ID 18061, 5 pages
doi:10.1155/MI/2006/18061
Short Communication

Detection of Erythropoietin in Exhaled Breath Condensate of Nonhypoxic Subjects Using a Multiplex Bead Array

Christian Schumann,1 Kathy Triantafilou,2 Stefan Krueger,1 Vinzenz Hombach,1 Martha Triantafilou,2 Gunther Becher,3 and Philipp M. Lepper1,4

1Department of Internal Medicine II, Section of Pulmonary Medicine, University of Ulm, Robert-Koch-Straβe 8 89081, Ulm, Germany
2Infection and Immunity Group, School of Life Sciences, University of Sussex, Brighton BN1 9QG, UK
3Research Society of Lung and Chest Diseases Ltd, Berlin 13125, Germany
4Department of Intensive Care Medicine, Inselspital, University of Bern, Bern 3010, Switzerland

Received 27 April 2006; Revised 23 August 2006; Accepted 23 August 2006

Copyright © 2006 Christian Schumann et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G E Carpagnano, S A Kharitonov, O Resta, M P Foschino-Barbaro, E Gramiccioni, and P J Barnes, “8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy,” Chest, vol. 124, no. 4, pp. 1386–1392, 2003.
  2. P Montuschi, S A Kharitonov, G Ciabattoni, and P J Barnes, “Exhaled leukotrienes and prostaglandins in COPD,” Thorax, vol. 58, no. 7, pp. 585–588, 2003.
  3. C Mondino, G Ciabattoni, P Koch, et al., “Effects of inhaled corticosteroids on exhaled leukotrienes and prostanoids in asthmatic children,” Journal of Allergy and Clinical Immunology, vol. 114, no. 4, pp. 761–767, 2004.
  4. U Sack, R Scheibe, M Wōtzel, et al., “Multiplex analysis of cytokines in exhaled breath condensate,” Cytometry Part A, vol. 69, no. 3, pp. 169–172, 2006.
  5. L Scheideler, H-G Manke, U Schwulera, O Inacker, and H Hammerle, “Detection of nonvolatile macromolecules in breath: a possible diagnostic tool?,” American Review of Respiratory Disease, vol. 148, no. 3, pp. 778–784, 1993.
  6. J Hunt, “Exhaled breath condensate: an evolving tool for noninvasive evaluation of lung disease,” Journal of Allergy and Clinical Immunology, vol. 110, no. 1, pp. 28–34, 2002.
  7. Z Z Chong, J-Q Kang, and K Maiese, “Angiogenesis and plasticity: role of erythropoietin in vascular systems,” Journal of Hematotherapy and Stem Cell Research, vol. 11, no. 6, pp. 863–871, 2002.
  8. Z Z Chong, J-Q Kang, and K Maiese, “Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades,” Journal of Cerebral Blood Flow and Metabolism, vol. 22, no. 5, pp. 503–514, 2002.
  9. S Genc, T F Koroglu, and K Genc, “Erythropoietin as a novel neuroprotectant,” Restorative Neurology and Neuroscience, vol. 22, no. 2, pp. 105–119, 2004.
  10. K Maiese and Z Z Chong, “Insights into oxidative stress and potential novel therapeutic targets for Alzheimer disease,” Restorative Neurology and Neuroscience, vol. 22, no. 2, pp. 87–104, 2004.
  11. K Sakamaki, “Regulation of endothelial cell death and its role in angiogenesis and vascular regression,” Current Neurovascular Research, vol. 1, no. 4, pp. 305–315, 2004.
  12. K Satoh, Y Kagaya, M Nakano, et al., “Important role of endogenous erythropoietin system in recruitment of endothelial progenitor cells in hypoxia-induced pulmonary hypertension in mice,” Circulation, vol. 113, no. 11, pp. 1442–1450, 2006.
  13. A E Tsantes, S I Papadhimitriou, S T Tassiopoulos, et al., “Red cell macrocytosis in hypoxemic patients with chronic obstructive pulmonary disease,” Respiratory Medicine, vol. 98, no. 11, pp. 1117–1123, 2004.
  14. M John, S Hoernig, W Doehner, D D Okonko, C Witt, and S D Anker, “Anemia and inflammation in COPD,” Chest, vol. 127, no. 3, pp. 825–829, 2005.
  15. M John, A Lange, S Hoernig, C Witt, and S D Anker, “Prevalence of anemia in chronic obstructive pulmonary disease: comparison to other chronic diseases,” International Journal of Cardiology, vol. 111, no. 3, pp. 365–370, 2006.
  16. I Horváth, J Hunt, P J Barnes, et al., “Exhaled breath condensate: methodological recommendations and unresolved questions,” European Respiratory Journal, vol. 26, no. 3, pp. 523–548, 2005.
  17. P H Quanjer, G J Tammeling, J E Cotes, O F Pedersen, R Peslin, and J C Yernault, “Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European community for steel and coal. Official statement of the European respiratory society,” The European Respiratory Journal. Supplement, vol. 16, pp. 5–40, 1993.
  18. C Gessner, S Hammerschmidt, H Kuhn, et al., “Exhaled breath condensate acidification in acute lung injury,” Respiratory Medicine, vol. 97, no. 11, pp. 1188–1194, 2003.
  19. C Gessner, S Hammerschmidt, H Kuhn, and H Wirtz, “Expired diagnosis?—The potential of exhaled breath analysis,” Pneumologie, vol. 58, no. 4, pp. 230–237, 2004.
  20. C Gessner, H Kuhn, K Toepfer, S Hammerschmidt, J Schauer, and H Wirtz, “Detection of p53 gene mutations in exhaled breath condensate of non-small cell lung cancer patients,” Lung Cancer, vol. 43, no. 2, pp. 215–222, 2004.
  21. C Gessner, R Scheibe, M Wōtzel, et al., “Exhaled breath condensate cytokine patterns in chronic obstructive pulmonary disease,” Respiratory Medicine, vol. 99, no. 10, pp. 1229–1240, 2005.
  22. K W Garey, M M Neuhauser, R A Robbins, L H Danziger, and I Rubinstein, “Markers of inflammation in exhaled breath condensate of young healthy smokers,” Chest, vol. 125, no. 1, pp. 22–26, 2004.
  23. D Kietzmann, R Kahl, M Muller, H Burchardi, and D Kettler, “Hydrogen peroxide in expired breath condensate of patients with acute respiratory failure and with ARDS,” Intensive Care Medicine, vol. 19, no. 2, pp. 78–81, 1993.
  24. R M Effros, K W Hoagland, M Bosbous, et al., “Dilution of respiratory solutes in exhaled condensates,” American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 5, pp. 663–669, 2002.
  25. R M Effros, J Biller, B Foss, et al., “A simple method for estimating respiratory solute dilution in exhaled breath condensates,” American Journal of Respiratory and Critical Care Medicine, vol. 168, no. 12, pp. 1500–1505, 2003.
  26. T M Dwyer, “Cigarette smoke-induced airway inflammation as sampled by the expired breath condensate,” American Journal of the Medical Sciences, vol. 326, no. 4, pp. 174–178, 2003.
  27. A Zacharasiewicz, N Wilson, C Lex, et al., “Repeatability of sodium and chloride in exhaled breath condensates,” Pediatric Pulmonology, vol. 37, no. 3, pp. 273–275, 2004.
  28. W Y Park, R B Goodman, K P Steinberg, et al., “Cytokine balance in the lungs of patients with acute respiratory distress syndrome,” American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 10 pt I, pp. 1896–1903, 2001.
  29. C J Parsa, J Kim, R U Riel, et al., “Cardioprotective effects of erythropoietin in the reperfused ischemic heart: a potential role for cardiac fibroblasts,” Journal of Biological Chemistry, vol. 279, no. 20, pp. 20655–20662, 2004.
  30. R M Effros, M B III Dunning, J Biller, and R Shaker, “The promise and perils of exhaled breath condensates,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 287, no. 6, pp. L1073–L1080, 2004.
  31. E Gianazza, L Allegra, E Bucchioni, et al., “Increased keratin content detected by proteomic analysis of exhaled breath condensate from healthy persons who smoke,” American Journal of Medicine, vol. 117, no. 1, pp. 51–54, 2004.
  32. A R Nissenson, S D Nimer, and D L Wolcott, “Recombinant human erythropoietin and renal anemia: molecular biology, clinical efficacy, and nervous system effects,” Annals of Internal Medicine, vol. 114, no. 5, pp. 402–416, 1991.